The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Centre — Val de Loire; Centre — Val de Loire; Eure-et-Loir
Location of affected unit(s)
Epernon
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
110 jobs Number of planned job losses
Announcement Date
25 September 2009
Employment effect (start)
1 October 2009
Foreseen end date
31 December 2009
Description
US pharmaceutical group Bristol-Myers Squibb has announced that the group will make 110 workers redundant with the closure of its plant in Epernon on 31 December 2009. Some other 30 workers will be transferred to the production plant in Agen (Lot-et-Garonne) and the remainder will be offered jobs at the company's headquarters in Rueil-Malmaison (Hauts-de-Seine).
The US group, which faces overcapacity in the production of ordinary drugs, has been trying to sell the plant for one year but did not manage to find a buyer. Bristol-Myers Squibb is also trying to sell the site of Meymac in central France.
Eurofound (2009), Bristol-Myers Squibb, Closure in France, factsheet number 69577, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/69577.